Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29711
Title: , Safety, Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With colchicine-resistant FMF: Results From the Phase 3 CLUSTER Trial
Authors: özen, S
Koné-Paut, I
Hofer, M
VAN DER HILST, Jeroen 
Gül, Ahmet
Brogan, Paul
Manna, Rafaelle
Issue Date: 2017
Source: 24th Pediatric Rheumatology Congress, Athens, Greece, 14/09/2017
Document URI: http://hdl.handle.net/1942/29711
DOI: 10.1186/s12969-017-0186-9
Category: C2
Type: Conference Material
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
published abstract canakinumab pediatric rheumatology.pdfConference material1.55 MBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.